Diagnostic Value of 18F-FDG PET/CT in Comparison to Bone Scintigraphy, CT and 18F-FDG PET for the Detection of Bone Metastasis |
Liu, Ning-Bo
(Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital)
Zhu, Lei (Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital) Li, Ming-Huan (Department of Radiation Oncology, Shandong Cancer Hospital) Sun, Xiao-Rong (Department of Nuclear Medicine, Shandong Cancer Hospital) Hu, Man (Department of Radiation Oncology, Shandong Cancer Hospital) Huo, Zong-Wei (PET/CT Center of Shandong Cancer Hospital) Xu, Wen-Gui (Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital) Yu, Jin-Ming (Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital) |
1 | Chang MC, Chen JH, Liang JA, et al (2013). Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: a systematic review and metaanalysis. Eur J Radiol, 82, 366-73. DOI ScienceOn |
2 | Choi YJ, Shin YD, Kang YH, et al (2012). The effects of preoperative (18)F-FDG PET/CT in breast cancer patients in comparison to the conventional imaging study. J Breast Cancer, 15, 441-8. DOI ScienceOn |
3 | Damle NA, Bal C, Bandopadhyaya GP, et al (2013). The role of (18)F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and (99m)Tc-MDP bone scan. Jpn J Radiol, 31, 262-9. DOI ScienceOn |
4 | Du Y, Cullum I, Illidge TM, et al (2007). Fusion of metabolic function and morphology, sequential 18F fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer. J Clin Oncol, 25, 3440-7. DOI ScienceOn |
5 | Evangelista L, Panunzio A, Polverosi R, et al (2012). Early bone marrow metastasis detection, the additional value of FDGPET/CT vs. CT imaging. Biomed Pharmacother, 66, 448-53. DOI ScienceOn |
6 | Fogelman I, Cook G, Israel O, et al (2005). Positron emission tomography and bone metastases. Semin Nucl Med, 35, 135-42. DOI ScienceOn |
7 |
Fuglo HM, Jorgensen SM, Loft A, et al (2012). The diagnostic and prognostic value of |
8 | Groheux D, Espié M, Giacchetti S, et al (2013). Performance of FDG PET/CT in the clinical management of breast cancer. Radiology, 266, 388-405. DOI ScienceOn |
9 | Iagaru A, Mittra E, Mosci C, et al (2013). Combined 18F-fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy, results of an international multicenter trial. J Nucl Med, 54, 176-83. DOI ScienceOn |
10 | Kato H, Miyazaki T, Nakajima M, et al (2005). Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas. Anticancer Res, 25, 4439-44. |
11 | Kim MR, Roh JL, Kim JS, et al (2008). 18F-Fluorodeoxyglucosepositron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract. Oral Oncol, 44, 148-52. DOI ScienceOn |
12 | Masi L, Brandi ML (2001). Physiopathological basis of bone turnover. Q J Nucl Med, 45, 2-6. |
13 | Lecouvet FE, El Mouedden J, Collette L, et al (2012). Can wholebody magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol, 62, 68-75. DOI ScienceOn |
14 | Liu N, Ma L, Zhou W, et al (2010). Bone metastasis in patients with non-small cell lung cancer: the diagnostic role of F-18 FDG PET/CT. Euro J of Radio, 74, 231-5. DOI ScienceOn |
15 | Montini KM, Tulchinsky M (2012). False-positive bone metastases on PET/CT secondary to sarcoidosis in a patient with rectal cancer. Clin Nucl Med, 37, 307-10. DOI |
16 | Riegger C, Herrmann J, Nagarajah J, et al (2012). Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients. Eur J Nucl Med Mol Imaging, 39, 852-63. DOI ScienceOn |
17 | Wu Y, Li P, Zhang H, et al (2013). Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/ computed tomography for the detection of metastases in nonsmall-cell lung cancer patients. Int J Cancer, 132, E37-47. DOI ScienceOn |
18 | Rybak LD, Rosenthal DI (2001). Radiological imaging for the diagnosis of bone metastases. Q J Nucl Med, 45, 53-64. |
19 | Shie P, Cardarelli R, Brandon D, et al (2008). Meta-analysis, comparison of F-18 Fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer. Clin Nucl Med, 33, 97-101. DOI ScienceOn |
20 |
Shinji I, Katsuhiko K, Mitsuru I, et al (2007). Comparison of |
21 | Yuji N, Christian C, Mitsuaki T, et al (2005). CT appearance of Bone Metastases Detected with FDG PET as part of the Same PET-CT Examination. Radiology, 237, 627-34. DOI ScienceOn |
22 |
Zaman MU, Fatima N, Sajjad Z (2011). Metastasis on bone scan with low prostate specific antigen ( |
![]() |